These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20467552)

  • 1. Drug research: marketing before evidence, sales before safety.
    Klemperer D
    Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
    [No Abstract]   [Full Text] [Related]  

  • 2. Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.
    Sen S; Prabhu M
    J Clin Psychopharmacol; 2012 Jun; 32(3):435. PubMed ID: 22561482
    [No Abstract]   [Full Text] [Related]  

  • 3. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
    Schott G; Pachl H; Limbach U; Gundert-Remy U; Ludwig WD; Lieb K
    Dtsch Arztebl Int; 2010 Apr; 107(16):279-85. PubMed ID: 20467553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on cost analysis of risperidone versus olanzapine.
    Duggal HS; Gandotra G
    J Clin Psychiatry; 2004 Jun; 65(6):879-80; author reply 880. PubMed ID: 15291670
    [No Abstract]   [Full Text] [Related]  

  • 5. Yes, industry influence is excessive.
    Shah AA; Finucane TE
    Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of selective publication on clinical research in pain.
    Rowbotham MC
    Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
    [No Abstract]   [Full Text] [Related]  

  • 7. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B
    BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
    [No Abstract]   [Full Text] [Related]  

  • 8. [The difficult relationship of industry and science. Money versus research].
    Wessling A
    Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence (letter to the editor): Need for advice.
    Grass G; Mäder K
    Dtsch Arztebl Int; 2010 Sep; 107(38):672; author reply 673-4. PubMed ID: 20953261
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical and political problems with a global research tax.
    Resnik DB
    Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971
    [No Abstract]   [Full Text] [Related]  

  • 11. Correspondence (letter to the editor): Trend gives cause for concern.
    Maier C; Zenz M
    Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
    [No Abstract]   [Full Text] [Related]  

  • 12. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

  • 13. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 14. Achieving greater independence from commercial influence in research.
    Lexchin J; Bero LA; Davis C; Gagnon MA
    BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982
    [No Abstract]   [Full Text] [Related]  

  • 15. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
    Berger E
    Ann Emerg Med; 2008 Aug; 52(2):137-9. PubMed ID: 18672488
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
    Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT
    Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 19. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

  • 20. Germany launches investigation into human trials scandal.
    Hyde R
    Lancet; 2013 Jul; 382(9887):115-6. PubMed ID: 23858551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.